Basic Information
Basic information for LINC01876-210-43aa
Peptide Name LINC01876-210-43aa
Genome Position chr2:156021060-156021188[-]
Species Human
Peptide Sequence MCSLAQKSVPAVSDVEGFSEILPITPGLLLNEQNILLGLEEVL
Peptide Length 43
Unique No (LINC01876-201-43aa,LINC01876-209-43aa,LINC01876-211-43aa,LINC01876-212-43aa,LINC01876-213-43aa)
Grand Average of Hydropathicity 0.6163
Relative Molecular Mass 5337.98
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000226383;LINC01876
Transcript ID/Name ENST00000657334;LINC01876-210
Transcript Length 1770
Coding Ability 0.3847
DNA Sequence Corresponding to Peptide ATGTGCTCTCTTGCACAGAAATCCGTGCCAGCAGTAAGTGATGTGGAAGGATTTAGTGAAATTTTGCCAATAACCCCAGGCTTACTGCTTAATGAACAGAACATTCTCCTGGGACTTGAAGAGGTCCTA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :